Binex Company Overview
- Founded
- 1957
- Status
- Public
- Employees
- 484
- Stock Symbol
- 053030
- Investments
- 3
- Share Price
- $25.21
- (As of Thursday Closing)
Binex Company General Information
Description
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.
Contact Information
Website
Formerly Known As
SoonCheonDang
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Stock Exchange
KRX
Primary Office
- 7-48 SongDo-Dong
- YeonSu-Gu
- Incheon, 406-840
- South Korea
+82 000-000-0000
Binex Company Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $25.21 | $24.64 | $4.98 - $35.10 | $787M | 31.2M | 3.99M | $0.37 |
Binex Company Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 825,667 | 212,013 | 259,858 | 321,691 |
| Revenue | 110,102 | 107,419 | 94,661 | 68,808 |
| EBITDA | 19,359 | 18,367 | 13,832 | (1,109) |
| Net Income | 11,693 | 7,293 | 5,766 | (9,960) |
| Total Assets | 186,537 | 175,061 | 170,278 | 157,003 |
| Total Debt | 13,122 | 20,191 | 21,807 | 24,116 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Binex Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Binex Company‘s full profile, request access.
Request a free trialBinex Company Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Myoung-Ho Jeong | Chief Executive Officer |
Binex Company Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBinex Company Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 11-Jun-2018 | 000000000 | 000.00 | Biotechnology | |
| 000000 00000000 (0 | 01-Sep-2015 | 000000000 00000 00 | 0000 | Buildings and Property | |
| Aprogen | 01-Jan-2012 | Corporate | Biotechnology |
Binex Company Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 | 01-Jan-2012 | 000000000 | Completed |
|